<DOC>
	<DOCNO>NCT00791817</DOCNO>
	<brief_summary>Half group give high fat diet half fast . They cross .</brief_summary>
	<brief_title>Study Evaluate Potential Food Effects</brief_title>
	<detailed_description>A food-effect study conduct time MRD study period one single cohort subject use 200 mg oral dose PG 760564 . Half group give high fat diet half fast . They ten cross .</detailed_description>
	<criteria>Healthy male surgically sterile postmenopausal ( last menstrual period &gt; 1 year time enrollment ) healthy female , 1845 year age , inclusive , screen ; Who use tobacco nicotinecontaining product within past 3 month ; Willing abstain caffeine xanthinecontaining beverage , include coffee tea , chocolate , alcohol , grapefruit juice , Seville oranges , 24 hour admission duration study ; Who body mass index ( BMI ) 18 32 kg/m2 , inclusive . History diabetes , cardiovascular , hepatic , renal , malabsorptive disease ; History diabetes , cardiovascular , hepatic , renal , malabsorptive disease ; History peptic ulcer disease , hemorrhoid , GI surgery ( appendectomy cholecystectomy allow ) , GI bleeding ; History autoimmune disease ; History immunodeficiency unusual susceptibility infectious disease ; History tuberculosis , acquire immunodeficiency syndrome ( AIDS ) , infection human immunodeficiency virus ( HIV ) ; Any history hypersensitivity clinically significant allergy drug ; Personal family history prolong QT syndrome cardiac conduction abnormality ; Family history sudden death ; History uveitis inflammatory ocular disease ; History peptic ulcer disease , hemorrhoid , GI surgery ( appendectomy cholecystectomy allow ) , GI bleeding ; History autoimmune disease ; History immunodeficiency unusual susceptibility infectious disease ; History tuberculosis , acquire immunodeficiency syndrome ( AIDS ) , infection human immunodeficiency virus ( HIV ) ; Any history hypersensitivity clinically significant allergy drug ; Personal family history prolong QT syndrome cardiac conduction abnormality ; Family history sudden death ; History uveitis inflammatory ocular disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>pharmacokinetics study</keyword>
</DOC>